Vidhya Bharathi

Vidhya Bharathi

Auto-generated profile, based on publicly available information

Vidhya Bharathi

Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Sangareddy, Telangana 502284, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2019 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
APArchana Prasad
Archana Prasad
VBVidhya Bharathi
Vidhya Bharathi
VSVishwanath Sivalingam
Vishwanath Sivalingam
AGAmandeep Girdhar
Amandeep Girdhar
BPBasant K. Patel
Basant K. Patel
TAR DNA binding protein 43 (TDP-43) is a versatile RNA/DNA binding protein involved in RNA-related metabolism. Hyper-phosphorylated and ubiquitinated TDP-43 deposits act as inclusion bodies in the brain and spinal cord of patients with the motor neuron diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). While the majority of ALS cases (90–95%) are sporadic (sALS), among familial ALS cases 5–10% involve the inheritance of mutations in the TARDBP gene and the remaining (90–95%) are due to mutations in other genes such as: C9ORF72, SOD1, FUS, and NEK1 etc. Strikingly however, the majority of sporadic ALS patients (up to 97%) also contain the TDP-43 protein deposited in the neuronal inclusions, which suggests of its pivotal role in the ALS pathology. Thus, unraveling the molecular mechanisms of the TDP-43 pathology seems central to the ALS therapeutics, hence, we comprehensively review the current understanding of the TDP-43's pathology in ALS. We discuss the roles of TDP-43's mutations, its cytoplasmic mis-localization and aberrant post-translational modifications in ALS. Also, we evaluate TDP-43's amyloid-like in vitro aggregation, its physiological vs. pathological oligomerization in vivo, liquid-liquid phase separation (LLPS), and potential prion-like propagation propensity of the TDP-43 inclusions. Finally, we describe the various evolving TDP-43-induced toxicity mechanisms, such as the impairment of endocytosis and mitotoxicity etc. and also discuss the emerging strategies toward TDP-43 disaggregation and ALS therapeutics.

22 September 2016 in Yeast
Verified
Journal Article
Open access
PDF file
VBVidhya Bharathi
Vidhya Bharathi
AGAmandeep Girdhar
Amandeep Girdhar
APArchana Prasad
Archana Prasad
MVMeenkshi Verma
Meenkshi Verma
VTVibha Taneja
Vibha Taneja
BPBasant K. Patel
Basant K. Patel
Mutations in adenine biosynthesis pathway genes ADE1 and ADE2 have been conventionally used to score for prion [PSI+] in yeast. If ade1‐14 mutant allele is present, which contains a premature stop codon, [psi−] yeast appear red on YPD medium owing to accumulation of a red intermediate compound in vacuoles. In [PSI+] yeast, partial inactivation of the translation termination factor, Sup35 protein, owing to its amyloid aggregation allows for read‐through of the ade1‐14 stop codon and the yeast appears white as the red intermediate pigment is not accumulated. The red colour development in ade1 and ade2 mutant yeast requires reduced‐glutathione, which helps in transport of the intermediate metabolite P‐ribosylaminoimidazole carboxylate into vacuoles, which develops the red colour. Here, we hypothesize that amyloid‐induced oxidative stress would deplete reduced‐glutathione levels and thus thwart the development of red colour in ade1 or ade2 yeast. Indeed, when we overexpressed amyloid‐forming human proteins TDP‐43, Aβ‐42 and Poly‐Gln‐103 and the yeast prion protein Rnq1, the otherwise red ade1 yeast yielded some white colonies. Further, the white colour eventually reverted back to red upon turning off the amyloid protein's expression. Also, the aggregate‐bearing yeast have increased oxidative stress and white phenotype yeast revert to red when grown on media with reducing agent. Furthermore, the red/white assay could also be emulated in ade2‐1, ade2Δ, and ade1Δ mutant yeast and also in an ade1‐14 mutant with erg6 gene deletion that increases cell‐wall permeability. This model would be useful tool for drug‐screening against general amyloid‐induced oxidative stress and toxicity. Copyright © 2016 John Wiley & Sons, Ltd.



1 January 2017 in Bio-Protocol
Verified
Journal Article
Closed access
VBVidhya Bharathi
Vidhya Bharathi
AGAmandeep Girdhar
Amandeep Girdhar
BPBasant Patel
Basant Patel
The yeast Saccharomyces cerevisiae (S. cerevisiae) harboring ade1 or ade2 mutations manifest red colony color phenotype on rich yeast medium YPD. In these mutants, intermediate metabolites of adenine biosynthesis pathway are accumulated. Accumulated intermediates, in the presence of reduced glutathione, are transported to the vacuoles, whereupon the development of the red color phenotype occurs. Here, we describe a method to score for presence of oxidative stress upon expression of amyloid-like proteins that would convert the red phenotype of ade1/ade2 mutant yeast to white. This assay could be a useful tool for screening for drugs with anti-amyloid aggregation or anti-oxidative stress potency.

21 August 2025 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
PSPreethi Saravanan
Preethi Saravanan
VBVidhya Bharathi
Vidhya Bharathi
PVPriyadarshini Veerabhadraswamy
Priyadarshini Veerabhadraswamy
BPBasant K Patel
Basant K Patel
Dyshomeostasis of TDP-43 protein is implicated in ALS. Here, solid-like in vitro aggregates of TDP-43 and its fragments induced by Zn2+ ions concurrently caused deep-blue autofluorescence (dbAF). UV exposure-induced protein damage also induced dbAF.